Last Updated on April 14, 2025 by tanya

Pregnancy Drug DES May Be A Cancer Risk

Can You Claim Compensation?

 

The pregnancy drug DES may be a cancer risk for both the women who took it and their daughters in the womb during pregnancy. The generational impact of the drug featured in a recent news investigation, highlighted potential links to an array of gynaecological health issues.

Concerns have been raised that the use of DES may have affected multiple generations. These women are known as ‘DES daughters’.

DES (Diethylstilbestrol) was used between the 1930s to 1973 when it was withdrawn after being proved to be carcinogenic. However, by that time, thousands of women had used it for different purposes. This included preventing miscarriages as well as for other pregnancy complications.

In some cases, it was used to suppress lactation among unmarried mothers who had given up their babies for adoption. The drug was officially banned for use in 1973.

 

A Multigenerational Health Crisis?

 

However, recent investigations suggest that DES’s impact may extend well beyond the women who originally took the drug. Their daughters and possibly even granddaughters, may be living with the consequences of exposure  to DES that occurred in the womb.

These women were unknowingly exposed to the drug during foetal development. Many have reported a range of reproductive health problems. This may include infertility, abnormal cell changes, and higher risks of certain cancers, particularly cervical and breast cancer.

There’s also concern that DES exposure could have affected a third generation, granddaughters of the original users. Although at this stage, though more research is needed.

 

Was There Institutional Prescribing?

 

It has also come to light that DES was routinely administered in some state institutions, to unmarried pregnant women during the 1950s to 70s. These women may not have been fully informed about the drug they were given. In many cases, their babies were placed for adoption with the mothers being prescribed DES to stop breast milk production.

 

Health Risks for DES Daughters

For women who were exposed to DES before birth, health risks are being reported.  This may include an increased likelihood of developing breast cancer after age 40. Other possible complications may include abnormalities of the reproductive organs and infertility.

 

Common Symptoms of Breast Cancer

 

Breast cancer is one of the leading causes of cancer among women globally. So, the warning signs of breast cancer is especially crucial for this group.

Early detection often leads to better outcomes, so knowing what to look for is key:

 

• Lumps or thickened tissue in the breast or underarm area
• Changes in breast shape or size, especially if one breast looks different from the other
• Skin dimpling or puckering, resembling an orange peel texture
• Nipple discharge, particularly if it’s bloody or occurs without pressure
• Nipple inversion or tenderness
• Persistent breast or underarm pain
• Swelling in part or all of the breast, even if no lump is present

 

While not every symptom means cancer, it’s important to speak with a healthcare provider if any of these changes occur.

 

Is Compensation Possible?

 

If you suspect that your health issues could be related to DES exposure, you may be eligible to start a personal injury claim.  You must be able to show that there is a clear link between your diagnosis and in-utero exposure to DES.

This may involve obtaining your mother’s medical records and expert medical opinions to support your case. Due to the historical nature of these claims, gathering the proper documentation can be complicated.

 

No Win, No Fee Claims For Compensation

 

We work with expert solicitors who handle cases on a ‘No Win, No Fee’ basis. Our team will evaluate your claim thoroughly and help you secure the justice and compensation you may be entitled to.

Contact First Personal Injury today at 0333 358 2345 or get in touch online for a free, no-obligation consultation to find out if you have a potential claim.